How Klow Supports Research Klow is designed to support pathway-focused research, not therapeutic use
historically, the FDA categorized pyridoxine as Pregnancy Category A for standard doses, indicating that controlled studies in pregnant women have not shown a risk to the fetus
Research on combination approaches remains limited, but the distinct delivery pathways suggest potential synergy
Van Haren RM, Mehran RJ, Mena GE, Correa AM, Antonoff MB , Baker CM, Woodard TC, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC
02 Topical product is causing irritation Community reports describe reducing frequency/concentration and avoiding strong actives